Company information:
Arysta Lifescience European Investments Limited (No: 08929295)
Address: CHARLOTTE HOUSE STANIER WAY, THE WYVERN BUSINESS PARK, DERBY, DE21 6BF
Status: Liquidation
Incorporated: 03-Jul-2014
Accounts Next Due: 31-Dec-2021
Next Confirmation Statement Due: 18-Apr-2021
Industry Class: 64209 - Activities of other holding companies n.e.c.
Current Director: MARK GORDON GIBBENS ( DOB: Jun-1967 From: Nov-2016 )
Current Director: MANDAR JAYANT KADAM ( DOB: Aug-1979 From: Jun-2019 )
Resigned Director: THOMAS ERIC BLASER ( From: Mar-2014 To: Apr-2015 )
Resigned Director: MARK GORDON GIBBENS ( DOB: Jun-1967 From: Nov-2016 To: Jun-2019 )
Resigned Director: WAYNE MAYLOR HEWETT ( From: Mar-2014 To: Aug-2015 )
Resigned Director: DAVID JACOBOSKI ( From: Jan-2016 To: Nov-2016 )
Resigned Director: BRYAN KOEPPL ( From: Apr-2015 To: Jan-2016 )
Resigned Director: FRANK JOSEPH MONTEIRO ( DOB: Feb-1970 From: Feb-2015 To: Aug-2015 )
Resigned Director: CHRISTOPHER GARETH JOSEPH RICHARDS ( DOB: Oct-1953 From: Mar-2014 To: Feb-2015 )
Resigned Secretary: JORDAN COMPANY SECRETARIES LIMITED ( From: Mar-2014 To: Feb-2016 )
Persons of Significant Control:
Arysta Lifescience U.K. Limited, Eversheds House 70 Great Bridgewater Street, Manchester, M1 5ES, United Kingdom: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2016-04-06)